Terkko Navigator / -/ Feeds / " ( ( Autoimmuunipolyendokrinopatiat )|( polyendocrinopathies, autoimmune )|( autoimmune "

Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED

Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome.

Prone-Positioning for Severe Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation.

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.

Clonal analysis of regulatory T cell defect in patients with autoimmune polyendocrine syndrome type 1 suggests intrathymic impairment.

Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.

Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.

Dermatitis herpetiformis arising within vitiligo in a patient with autoimmune polyendocrine syndrome type 3.

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma.

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma.

ICPis -induced autoimmune polyendocrine syndrome type 2: a review of the literature and a protocol for optimal management.

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma

Clonal Analysis of Regulatory T Cell Defect in Patients with Autoimmune Polyendocrine Syndrome Type 1 Suggests Intrathymic Impairment

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections

Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1

Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity

Postpartum thyroiditis as the first clinical manifestation of autoimmune polyendocrine syndrome type 2– case report

Oral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1.

Oral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1.

Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment

Case of autoimmune polyendocrine syndrome type 3 complicated with anti‐N‐methyl‐D‐aspartic acid‐receptor encephalitis

ICPis -induced autoimmune polyendocrine syndrome type 2: a review of the literature and a protocol for optimal management.

ICPis -induced autoimmune polyendocrine syndrome type 2: a review of the literature and a protocol for optimal management.

ICPis -induced autoimmune polyendocrine syndrome type 2: a review of the literature and a protocol for optimal management.

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma

A Case Report of Fatal Mucormycosis in a 30-Year-Old Patient with Autoimmune Polyendocrine Syndrome Type 1

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma

Multiple endocrine deficiencies are common in Hypoparathyroidism-Retardation-Dysmorphism (HRD) Syndrome.

Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator.

Gastrointestinal Manifestations in APECED Syndrome.

Pregnancy Outcome in Women With APECED (APS-1) : A Multicenter Study on 43 Females With 83 Pregnancies

Pubertal development and premature ovarian insufficiency in patients with APECED.

Pubertal development and premature ovarian insufficiency in patients with APECED

Pubertal development and premature ovarian insufficiency in patients with APECED

Aire Deficiency Causes Increased Susceptibility to Streptozotocin-induced Murine Type 1 Diabetes.

Heavy Exposure of Children Aged 9–12 Years With Severe Acute Respiratory Syndrome Coronavirus 2 Did Not Lead to Infection

Biomedicines, Vol. 9, Pages 1274: B Cells and Autoantibodies in AIRE Deficiency

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy

Autoimmune regulator (AIRE) contributes to Dectin-1-induced TNF-? production and complexes with caspase recruitment domain-containing protein 9 (CARD9), spleen tyrosine kinase (Syk), and Dectin-1.

Autoimmune regulator (AIRE) contributes to Dectin-1-induced TNF-? production and complexes with caspase recruitment domain-containing protein 9 (CARD9), spleen tyrosine kinase (Syk), and Dectin-1.

Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)

Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)

Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)

Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)

APECED: is this a model for failure of T cell and B cell tolerance?

Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: New views on molecular basis of autoimmunity.